QMED — QMed Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.33m
- $5.25m
Annual cashflow statement for QMed, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2003 November 30th | 2004 November 30th | R2005 November 30th | R2006 November 30th | 2007 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.15 | -1.74 | 3.89 | -14.2 | -11.3 |
Depreciation | |||||
Non-Cash Items | 0.562 | 0.864 | 1.43 | 1.88 | -1.54 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.151 | -3.1 | -0.561 | 3.56 | -1.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.03 | -3.5 | 5.38 | -7.92 | -12.7 |
Capital Expenditures | -0.238 | -0.641 | -0.625 | -1.44 | -0.396 |
Purchase of Fixed Assets | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | 0.346 | 3.43 | -18.7 | 7.64 | 11.7 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.108 | 2.79 | -19.3 | 6.2 | 11.3 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.182 | 2.37 | 14.7 | -0.013 | 0.355 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.745 | 1.65 | 0.747 | -1.73 | -1.12 |